AbCellera Biologics Inc. (ABCL) vs ICU Medical, Inc. (ICUI)
A side-by-side comparison of AbCellera Biologics Inc. and ICU Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABCL
AbCellera Biologics Inc.
$13.79HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
ICUI
ICU Medical, Inc.
$160.05HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
Total return — ABCL vs ICUI
growth of $100 · dividends reinvested · last 6yABCL -76.6% (-21.5%/yr)ICUI -15.4% (-2.7%/yr)ICUI compounded faster over this window
ABCL ICUI
ABCL vs ICUI: by the numbers
- •ABCL is the larger company ($4.21B vs $4.00B market cap).
- •ICUI is profitable (1.39% net margin) while ABCL runs a net loss (-248.83%).
- •ICUI grew revenue faster over the past five years (11.05% vs -31.78% CAGR).
Metrics side by side
Valuation
| Metric | ABCL | ICUI |
|---|---|---|
| P/E ratio | N/A | 135.64 |
| P/S ratio | 63.64 | 1.85 |
| P/B ratio | 4.70 | 1.86 |
| EV / EBITDA | N/A | 13.68 |
| FCF yield | N/A | 3.82% |
Profitability
| Metric | ABCL | ICUI |
|---|---|---|
| Gross margin | 61.64% | 37.56% |
| Operating margin | -288.98% | 5.04% |
| Net margin | -248.83% | 1.39% |
| ROE | -18.38% | 1.40% |
| ROIC | -17.95% | 3.11% |
Growth (annualized)
| Metric | ABCL | ICUI |
|---|---|---|
| Revenue CAGR (5Y) | -31.78% | 11.05% |
| EPS CAGR (5Y) | N/A | -62.79% |
| FCF CAGR (5Y) | N/A | -2.65% |
| Total return CAGR (5Y) | -3.57% | -7.18% |
Frequently asked
- Which has grown faster, ABCL or ICUI?
- Over the past five years, ICUI grew revenue faster — ABCL at a -31.78% CAGR versus ICUI at 11.05%.
- Is ABCL or ICUI more profitable?
- ICUI runs the higher net margin — ABCL at -248.83% versus ICUI at 1.39%.
- How have ABCL and ICUI total returns compared?
- Over the past 5 years, ABCL delivered -3.57% and ICUI delivered -7.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.